CVB homepage

Inomagen Therapeutics Inc. is developing a gene therapy to treat atrial fibrillation (AFib) that will be delivered using electroporation directly into cardiac cells.

The therapy, if successful, could eliminate the need for patients to take drugs or undergo invasive catheter ablation procedures.

Examples of OCT (left) and IVUS (right) images of two different subjects with calcium. Blue arrows denote calcium noted on OCT, red asterisks mark calcium on IVUS

The team behind this new meta-analysis reviewed data from more than 24,000 patients with a mean age of nearly 65 years old. They identified several benefits to choosing intravascular imaging guidance during PCI over traditional angiography alone.

business handshake

Johnson & Johnson is selling key assets related to its Laminar program to a new startup, Jaguar LAA. This comes less than three years after Johnson & Johnson acquired Laminar for $400 million. 

oatmeal healthy diet banana

Eating four to six servings of whole-grain foods per day is associated with multiple cardiovascular benefits, according to a new meta-analysis of dozens of clinical trials. 

The ACCESS model is designed help more patients get treated and managed with advanced technologies. In addition to heart failure, improved coverage has been announced for Medicare beneficiaries battling COPD, substance use disorders and nicotine dependence.

XCath Robotics, a Houston-based medical robotics company, announced the successful completion of the world’s first telerobotic stroke operation of its kind. Neurosurgeon Vitor Mendes Pereira, MD, chair of advanced neurovascular interventions at the University of Toronto, used the XCath Iris Surgical Robotic System to perform the historic procedure.

XCath Robotics has received the FDA's breakthrough device designation for its Iris surgical robotic system. The device is used to perform remote robotic-assisted mechanical thrombectomy on patients with acute ischemic stroke.